CTX-0294885 is a novel potent and broad-spectrum kinase inhibitor and a sepharose-supported kinase capture reagent which exhibits inhibitory activity against a broad range of kinases in vitro. The selectivity of CTx - 0294885 -bound beads for kinase enrichment was confirmed through the use of a quantitative proteomics approach. The identification of 235 protein kinases from MDA-MB-231 cells, including all members of the AKT family that had not previously been identified by other broad-spectrum kinase inhibitors, was made possible by large-scale CTX- 0294885 -based affinity purification and LC-MS/MS. A potent new tool for studying kinome signaling networks, CTX- 0294885 may make it easier to create individualized treatment plans.
Physicochemical Properties
| Molecular Formula | C22H24CLN7O |
| Molecular Weight | 437.93 |
| Exact Mass | 437.173 |
| Elemental Analysis | C, 60.34; H, 5.52; Cl, 8.10; N, 22.39; O, 3.65 |
| CAS # | 1439934-41-4 |
| Related CAS # | CTX-0294885 hydrochloride |
| PubChem CID | 71558939 |
| Appearance | white solid powder |
| Density | 1.3±0.1 g/cm3 |
| Index of Refraction | 1.674 |
| LogP | 2.22 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 31 |
| Complexity | 568 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | ClC1=C([H])N=C(N=C1N([H])C1=C([H])C([H])=C([H])C([H])=C1C(N([H])C([H])([H])[H])=O)N([H])C1C([H])=C([H])C(=C([H])C=1[H])N1C([H])([H])C([H])([H])N([H])C([H])([H])C1([H])[H] |
| InChi Key | FCLOIQHNUARDSR-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C22H24ClN7O/c1-24-21(31)17-4-2-3-5-19(17)28-20-18(23)14-26-22(29-20)27-15-6-8-16(9-7-15)30-12-10-25-11-13-30/h2-9,14,25H,10-13H2,1H3,(H,24,31)(H2,26,27,28,29) |
| Chemical Name | 2-[[5-chloro-2-(4-piperazin-1-ylanilino)pyrimidin-4-yl]amino]-N-methylbenzamide |
| Synonyms | CTX0294885 CTX 0294885 CTX-0294885 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | CTX-0294885 is a kinase capture tool in large-scale kinome profiling experiments, with 185 kinases identified as total protein, and 179 identified from TiO2 enrichment for phosphopeptides in MDA-MB-231 cells (by quantitative MS)[1]. CTX-0294885 captures all members of the AKT family that is not identified from previous studies using other kinase capture reagents[1].CTX-0294885 is a kinase capture tool in large-scale kinome profiling experiments, with 185 kinases identified as total protein, and 179 identified from TiO2 enrichment for phosphopeptides in MDA-MB-231 cells (by quantitative MS)[1]. |
| References |
[1]. Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling. J Proteome Res. 2013 Jul 5;12(7):3104-16. |
Solubility Data
| Solubility (In Vitro) | DMSO: ≥100 mg/mL (~228.4 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.71 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (5.71 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.2835 mL | 11.4173 mL | 22.8347 mL | |
| 5 mM | 0.4567 mL | 2.2835 mL | 4.5669 mL | |
| 10 mM | 0.2283 mL | 1.1417 mL | 2.2835 mL |